Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-21-005004
Filing Date
2021-02-26
Accepted
2021-02-26 16:09:15
Documents
1
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 5474
  Complete submission text file 0001567619-21-005004.txt   7284
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Reporting) CIK: 0001587114 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-35676 | Film No.: 21688801